MoschamineCAS# 68573-23-9 |
- cis-Moschamine
Catalog No.:BCN3901
CAS No.:193224-24-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 68573-23-9 | SDF | Download SDF |
| PubChem ID | 5969616 | Appearance | Powder |
| Formula | C20H20N2O4 | M.Wt | 352.39 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide | ||
| SMILES | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CNC3=C2C=C(C=C3)O)O | ||
| Standard InChIKey | WGHKJYWENWLOMY-XVNBXDOJSA-N | ||
| Standard InChI | InChI=1S/C20H20N2O4/c1-26-19-10-13(2-6-18(19)24)3-7-20(25)21-9-8-14-12-22-17-5-4-15(23)11-16(14)17/h2-7,10-12,22-24H,8-9H2,1H3,(H,21,25)/b7-3+ | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Moschamine may suppress cAMP formation via binding to 5-HT1 receptors in the cells. 2. Moschamine is a very potent compound that is able to inhibit COX-I by 58% and COX-II by 54%, at the concentration of 0.1 μmol L⁻1. 3. Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells. |
| Targets | COX | cAMP | 5-HT Receptor |
Moschamine Dilution Calculator
Moschamine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.8378 mL | 14.1888 mL | 28.3776 mL | 56.7553 mL | 70.9441 mL |
| 5 mM | 0.5676 mL | 2.8378 mL | 5.6755 mL | 11.3511 mL | 14.1888 mL |
| 10 mM | 0.2838 mL | 1.4189 mL | 2.8378 mL | 5.6755 mL | 7.0944 mL |
| 50 mM | 0.0568 mL | 0.2838 mL | 0.5676 mL | 1.1351 mL | 1.4189 mL |
| 100 mM | 0.0284 mL | 0.1419 mL | 0.2838 mL | 0.5676 mL | 0.7094 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Pridinol Methanesulfonate
Catalog No.:BCC3845
CAS No.:6856-31-1
- Eupatoriopicrin
Catalog No.:BCN7116
CAS No.:6856-01-5
- GSK 264220A
Catalog No.:BCC6062
CAS No.:685506-42-7
- Cilostamide
Catalog No.:BCC6843
CAS No.:68550-75-4
- Isoguvacine hydrochloride
Catalog No.:BCC6575
CAS No.:68547-97-7
- Angiotensin II
Catalog No.:BCC1030
CAS No.:68521-88-0
- Vigabatrin
Catalog No.:BCC2039
CAS No.:68506-86-5
- Pramiracetam
Catalog No.:BCC4928
CAS No.:68497-62-1
- WS 12
Catalog No.:BCC7543
CAS No.:68489-09-8
- Coromandaline
Catalog No.:BCN2044
CAS No.:68473-86-9
- Heliovicine
Catalog No.:BCN2047
CAS No.:68473-85-8
- 4-(p-Biphenylyl)-3-hydroxybutyric acid
Catalog No.:BCN2240
CAS No.:6845-17-6
- Prometaphanine
Catalog No.:BCN4244
CAS No.:6858-85-1
- PX-478 2HCl
Catalog No.:BCC6502
CAS No.:685898-44-6
- Isorhyncophylline
Catalog No.:BCN3466
CAS No.:6859-01-4
- Isorhynchophylline
Catalog No.:BCN6458
CAS No.:6859-1-4
- Xylobiose
Catalog No.:BCN8424
CAS No.:6860-47-5
- Procerine
Catalog No.:BCN2017
CAS No.:68622-81-1
- Otenabant
Catalog No.:BCC1828
CAS No.:686344-29-6
- CP-945598 HCl
Catalog No.:BCC1082
CAS No.:686347-12-6
- BOP-Cl
Catalog No.:BCC2808
CAS No.:68641-49-6
- (±)-Palmitoylcarnitine chloride
Catalog No.:BCC6718
CAS No.:6865-14-1
- IWP-2
Catalog No.:BCC1665
CAS No.:686770-61-6
- BC 11-38
Catalog No.:BCC7940
CAS No.:686770-80-9
Bioactivity-guided isolation of antiproliferative compounds from Centaurea arenaria.[Pubmed:21031625]
Phytother Res. 2010 Nov;24(11):1664-9.
The antiproliferative effects of n-hexane, chloroform and aqueous methanol extracts prepared from the whole plant of Centaurea arenaria M.B. ex Willd. were investigated against cervix adenocarcinoma (HeLa), breast adenocarcinoma (MCF7) and skin epidermoid carcinoma (A431) cells, using the MTT assay. The chloroform extract displayed high tumour cell proliferation inhibitory activity (higher than 85% at 10 mug/mL concentration), and was therefore subjected to a bioassay-guided multistep separation procedure. Flavonoids (eupatilin, eupatorin, 3'-methyleupatorin, apigenin and isokaempferid), lignans (arctigenin, arctiin and matairesinol), the sesquiterpene cnicin, serotonin conjugates (Moschamine and cis-Moschamine), beta-amyrin and beta-sitosterin-beta-D-glycopyranoside, identified by means of UV, MS and NMR spectroscopy, were obtained for the first time from this species. The isolated compounds were also evaluated for their tumour cell growth inhibitory activities on HeLa, MCF7 and A431 cells, and different types of secondary metabolites were found to be responsible for the antitumour effects of the extracts; in addition to moderately active compounds (isokaempferid and Moschamine), especially apigenin, eupatorin, arctigenin, arctiin, matairesinol and cnicin exert marked antitumour effects against these cell lines.
Synthesis, biological activities and bioavailability of moschamine, a safflomide-type phenylpropenoic acid amide found in Centaurea cyanus.[Pubmed:21978225]
Nat Prod Res. 2012;26(16):1465-72.
Moschamine is a phenylpropenoic acid amide found in plants. In this article, the synthesis and two biological activities (serotoninergic and cyclooxygenase (COX) inhibitory activities) and bioavailability of Moschamine were described. Moschamine was synthesised and confirmed using NMR spectroscopic methods. Using the Moschamine synthesised, serotoninergic and COX inhibitory activities were investigated. At the concentration of 10 micromol L(-)(1), Moschamine was able to inhibit forskolin-stimulated cAMP formation by 25% (p < 0.015), via inhibiting serotonin receptors in the OK cells. The inhibition was repressed by two 5-HT1 antagonists (Nan-190 and spiperone), suggesting that Moschamine may suppress cAMP formation via binding to 5-HT1 receptors in the cells. Also, Moschamine was a very potent compound that is able to inhibit COX-I by 58% (p < 0.012) and COX-II by 54% (p < 0.014), at the concentration of 0.1 micromol L(-)(1). The oral bioavailability of Moschamine was also determined in mice.
